GLP-1 RAs are associated with reduced type 2 diabetes mellitus (T2DM)-related dementia risk compared with metformin.

For older adults with diabetes, there is no evidence to suggest that the incidence of dementia differs for those using GLP-1 RAs vs DPP4is.

"Dentist here. STOP SMOKING. Smoking leads to bad oral health and mouth cancers. Bad oral health can lead to blood infections ...

Discover the critical connection between diabetes and heart disease, learn how to manage risks, and find out what preventive ...

India accounts for 1 in 7 adults living with diabetes globally. An estimated 89.8 million adults aged 20-79 years in India ...

C, the 'bad cholesterol', is a crucial factor in heart disease. Learn from experts how reducing LDL-C can save lives, ...

Discontinuation of GLP-1 receptor agonists suggested before conception rather than between start of pregnancy and end of first trimester.

SGLT2 inhibitors, compared with GLP-1 RAs, were associated with lower risks for osteoarthritis and joint replacement surgery among patients with T2D.

Researchers have found in a new research that SGLT2 inhibitors may provide dual benefits in treating both diabetes and fatty ...

Individualized ocular characteristics should be considered before starting GLP-1 RA therapies for weight loss and diabetes management.